Purnanand Sarma
Direktor/Vorstandsmitglied bei Ohm Oncology, Inc.
Vermögen: 6 Mio $ am 30.04.2024
Profil
Purnanand D.
Sarma is currently a Director at Ohm Oncology, Inc. He was previously the President, Chief Executive Officer & Director at TARIS BioMedical LLC from 2013 to 2019, and is a former VP & GM-Worldwide Drug Delivery Technologies at Cephalon, Inc. He has also held positions at CIMA Labs, Inc., Nektar Therapeutics, and Smithkline Beecham Pharmaceuticals (India) Ltd.
Sarma holds a doctorate from the University of Minnesota and an undergraduate degree from Andhra University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOME, INC.
0,73% | 01.04.2024 | 435 315 ( 0,73% ) | 6 Mio $ | 30.04.2024 |
Aktive Positionen von Purnanand Sarma
| Unternehmen | Position | Beginn |
|---|---|---|
Ohm Oncology, Inc.
 Ohm Oncology, Inc. Pharmaceuticals: MajorHealth Technology Ohm Oncology, Inc. is a drug development company. It treats drug resistant neoplasms and cancers with novel multi-mechanism compounds. The company was founded by Vamsi Maddipatla and Ram S. Upadhayaya and is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Purnanand Sarma
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOME, INC. | Vorstandsvorsitzender | 02.10.2023 |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Vorstandsvorsitzender | 03.01.2019 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | - |
Vaxess Technologies, Inc.
 Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Corporate Officer/Principal | - |
Ausbildung von Purnanand Sarma
| University of Minnesota | Doctorate Degree |
| Andhra University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| IMMUNOME, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Health Technology |
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Health Technology |
| Smithkline Beecham Pharmaceuticals (India) Ltd. | Health Technology |
Ohm Oncology, Inc.
Ohm Oncology, Inc. Pharmaceuticals: MajorHealth Technology Ohm Oncology, Inc. is a drug development company. It treats drug resistant neoplasms and cancers with novel multi-mechanism compounds. The company was founded by Vamsi Maddipatla and Ram S. Upadhayaya and is headquartered in Austin, TX. | Health Technology |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Commercial Services |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |